| abstract |
A daily dose or more daily doses of an aromatase inhibitor (AI) for administration during the assisted reproductive cycle or the ovulation induction cycle, the days being selected from an amount effective to reduce serum estradiol levels. Use of at least one aromatase inhibitor in the manufacture of a medicament for improving implantation and pregnancy rates in females receiving assisted reproductive therapy, comprising a dose of AI. Related pharmaceutical preparations and packages are also disclosed. |